Catalyst Wire Dossier Catalyst Wire Dossier

Motavizumab

motavizumab · MedImmune
Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for Motavizumab, covering 2012-08-01 to 2021-08-27. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate a Single Intravenous Dose of Motavizumab for the Treatment of Children Hospitalized With Respiratory Syncytial Virus (RSV) Illness [NA]

See pricing